Literature DB >> 24315797

The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia.

Borek Sehnal1, Ladislav Dusek2, David Cibula3, Tomas Zima4, Michael Halaska5, Daniel Driak5, Jiri Slama3.   

Abstract

BACKGROUND: More than 90% of cases of anal cancers are caused by high-risk human papillomavirus (HR HPV) infection and a history of cervical intraepithelial neoplasia (CIN) is established as possible risk factor.
OBJECTIVES: To demonstrate relationship between anal and cervical HPV infection in women with different grades of CIN and microinvasive cervical cancer. STUDY
DESIGN: A total of 272 women were enrolled in the study. The study group included 172 women who underwent conization for high-grade CIN or microinvasive cervical cancer. The control group consisted of 100 women with non-neoplastic gynecologic diseases or biopsy-confirmed CIN 1. All participants completed a questionnaire detailing their medical history and sexual risk factors and were subjected to anal and cervical HPV genotyping using Cobas and Lynear array HPV test.
RESULTS: Cervical, anal, and concurrent cervical and anal HPV infections were detected in 82.6%, 48.3% and 42.4% of women in the study group, and in 28.0%, 26.0% and 8.0% of women in the control group, respectively. The prevalence of the HR HPV genotypes was higher in the study group and significantly increased with the severity of cervical lesion. Concurrent infections of the cervix and anus occurred 5.3-fold more often in the study group than in the control group. Any contact with the anus was the only significant risk factor for development of concurrent HPV infection.
CONCLUSIONS: Concurrent anal and cervical HR HPV infection was found in nearly half of women with CIN 2+. The dominant genotype found in both anatomical locations was HPV 16. Any frequency and any type of contact with the anus were shown as the most important risk factor for concurrent HPV infection.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AIN; AIS; ASC-H; Anal cancer; Anal infection; CIN; CIN 2+; COC; Cervical infection; DNA; HIV; HPV; HR; HRT; HSIL; IUD; LR; OR; PCR; adenocarcinoma in situ; anal intraepithelial neoplasia; atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion; cervical intraepithelial neoplasia; combined oral contraception; deoxyribonucleic acid; high-grade squamous intraepithelial lesion; high-gradeCIN or microinvasive cervical cancer; high-risk; hormone replacement therapy; human immunodeficiency virus; human papillomavirus; intrauterine device; low-risk; odd ratio; polymerase chain reaction

Mesh:

Year:  2013        PMID: 24315797     DOI: 10.1016/j.jcv.2013.11.004

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  11 in total

1.  Anal human papillomavirus (HPV) prevalences and factors associated with abnormal anal cytology in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil.

Authors:  Mary C Cambou; Paula M Luz; Jordan E Lake; José Eduardo Levi; José Ricardo Coutinho; Angela de Andrade; Thais Heinke; Mônica Derrico; Valdilea G Veloso; Ruth K Friedman; Beatriz Grinsztejn
Journal:  AIDS Patient Care STDS       Date:  2015-01       Impact factor: 5.078

2.  Prevalence of Anal HPV and Anal Dysplasia in HIV-Infected Women From Johannesburg, South Africa.

Authors:  Bridgette J Goeieman; Cynthia S Firnhaber; Eefje Jong; Pam Michelow; Patricia Kegorilwe; Avril Swarts; Anna-Lise Williamson; Bruce Allan; Jennifer S Smith; Timothy J Wilkin
Journal:  J Acquir Immune Defic Syndr       Date:  2017-07-01       Impact factor: 3.731

3.  Tracking vaginal, anal and oral infection in a mouse papillomavirus infection model.

Authors:  Jiafen Hu; Lynn R Budgeon; Nancy M Cladel; Karla Balogh; Roland Myers; Timothy K Cooper; Neil D Christensen
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

Review 4.  Screening for Anal Cancer in Women.

Authors:  Anna-Barbara Moscicki; Teresa M Darragh; J Michael Berry-Lawhorn; Jennifer M Roberts; Michelle J Khan; Lori A Boardman; Elizabeth Chiao; Mark H Einstein; Stephen E Goldstone; Naomi Jay; Wendy M Likes; Elizabeth A Stier; Mark L Welton; Dorothy J Wiley; Joel M Palefsky
Journal:  J Low Genit Tract Dis       Date:  2015-07       Impact factor: 1.925

5.  Prevalence of human papillomavirus infection of the anal canal in women: A prospective analysis of high-risk populations.

Authors:  Bernd P Kost; Jörg Hofmann; Susanne Stoellnberger; Florian Bergauer; Thomas Blankenstein; Irene Alba-Alejandre; Angela Stein; Claudia Stuckart; Katharina Weizsäcker; Ioannis Mylonas; Sven Mahner; Andrea Gingelmaier
Journal:  Oncol Lett       Date:  2017-02-10       Impact factor: 2.967

Review 6.  HPV Update: Vaccination, Screening, and Associated Disease.

Authors:  Megan McNamara; Pelin Batur; Judith M E Walsh; Kay M Johnson
Journal:  J Gen Intern Med       Date:  2016-05-16       Impact factor: 5.128

7.  A prospective study of treatments for cervical intraepithelial neoplasia and fecundability.

Authors:  Lauren A Wise; Sydney K Willis; Rebecca B Perkins; Amelia K Wesselink; Alexandra Klann; Holly M Crowe; Kristen A Hahn; Ellen M Mikkelsen; Elizabeth E Hatch
Journal:  Am J Obstet Gynecol       Date:  2019-12-28       Impact factor: 8.661

8.  Patients with newly diagnosed cervical cancer should be screened for anal human papilloma virus and anal dysplasia: Results of a pilot study using a STELLA computer simulation and economic model.

Authors:  Eli D Ehrenpreis; Dylan G Smith
Journal:  Papillomavirus Res       Date:  2017-12-13

9.  HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix.

Authors:  Wenbo Long; Zixi Yang; Xiabin Li; Ming Chen; Jie Liu; Yuanxue Zhang; Xingwang Sun
Journal:  Virol J       Date:  2018-05-25       Impact factor: 4.099

10.  The association among cervical, anal, and oral HPV infections in high-risk and low-risk women.

Authors:  Borek Sehnal; Michal Zikan; Monika Nipcova; Ladislav Dusek; David Cibula; Jiri Slama
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.